Rabbit polyclonal to MCP2 ( Abpromise for all tested applications). entrezGeneID: 6355 SwissProtID: P49873...
... speed homogeneous assay for the detection of ... of inhibitors in a high-throughput screening (HTS) ... fluorescence superquenching technology that does not require ... provides flexibility for assaying any kinase or ...
... The Rotofor purification system with PowerPac 3000 ... protein separation and purification by liquid-phase isoelectric ... mini (18 ml) and standard (60 ml) ... electrode chambers, PowerPac 3000 power supply, 10 ...
... purification system, 100-120 V, is used for ... focusing (IEF). The system includes both the ... focusing chambers, chassis, harvesting apparatus, cooling finger, ... 3-10), 60 ml syringe, colored protein sample, ...
Biology Products:... vitamin D, once linked to only bone diseases such as ... in contributing to overall human health, emphasizes UC Riverside,s ... In a paper published in the August issue of the ... identifies vitamin D,s potential for contributions to good health in ...
... 9th, 2008 The United States lacks the policies needed ... environmental harm, says a distinguished group of international scientists. ... the journal Science, urges decision makers to ... future production efforts are sustainable, both energetically and environmentally. ...
... boost ozone pollution to levels that violate U.S. health ... at the National Center for Atmospheric Research (NCAR), focused ... caused ground-level ozone to spike to unhealthy levels across ... well as neighboring Nevada. , The study was published ...
Other Biology News:Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist 2Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist 3Experts agree: to protect the environment, biofuel standards are needed 2Wildfires cause ozone pollution to violate health standards, new study shows 2Wildfires cause ozone pollution to violate health standards, new study shows 3(Date:2/9/2010)... AMSTERDAM , February 9 ,Agendia, ... today that,it has received the Clinical Laboratory Permit ... Health. The New York State permit ... its FDA-cleared breast cancer recurrence,test. ,, ... now obtained all major U.S. clinical,laboratory licenses. In ...
(Date:2/9/2010)... February 9 ,, ... of Microplasmin to Improve the Treatment,of a Range ... ThromboGenics NV (Euronext Brussels: THR), ... of innovative treatments for eye,disease, vascular disease and ... trial results, evaluating the product,s efficacy and,safety in ...
(Date:2/8/2010)... Feb. 8 /PRNewswire-FirstCall/ - YM BioSciences ... operational and financial results for the second quarter ... . ,, "After rigorous evaluation of numerous global ... a clinical-stage, Melbourne -based drug development company, ... David Allan , Chairman & CEO of YM ...
(Date:2/8/2010)... CMED ), a leading China -based advanced in-vitro,diagnostic ("IVD") company, today announced that it ... Investor Conference Date ... & Renshaw Annual March 7-9, 2010 The ... ... Credit Suisse Asian March 22-26, ...
Breaking Biology Technology:Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists 2ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 2ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 3ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology 4YM BioSciences reports second quarter 2010 operational and financial results 2YM BioSciences reports second quarter 2010 operational and financial results 3YM BioSciences reports second quarter 2010 operational and financial results 4YM BioSciences reports second quarter 2010 operational and financial results 5YM BioSciences reports second quarter 2010 operational and financial results 6YM BioSciences reports second quarter 2010 operational and financial results 7YM BioSciences reports second quarter 2010 operational and financial results 8YM BioSciences reports second quarter 2010 operational and financial results 9YM BioSciences reports second quarter 2010 operational and financial results 10YM BioSciences reports second quarter 2010 operational and financial results 11YM BioSciences reports second quarter 2010 operational and financial results 12China Medical Technologies to Participate Investor Conferences in March 2010 2Biology NavigationMedical Navigation